Evaluation of Monocyte Subpopulations in Patients with Systemic Sclerosis and its Association with Clinical Manifestations of the Disease: a Cross-sectional Controlled Study.
Elham SafarzadehVahid AsghariazarShohreh PordelElham BaghbaniAsgar FekriAfsaneh Enteshari-MoghaddamPublished in: Iranian journal of immunology : IJI (2024)
Our results showed an increase in the level of CD16+ monocytes in patients with SSc compared to healthy individuals. Further investigation is required to determine the clinical significance of this alteration.